Floatz logo

Itavastatin

Abdominal Obesity-Metabolic Syndrome

Seoul National University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
73/ 100

Competitive context

42 Active assets in the Abdominal Obesity-Metabolic Syndrome cohort.

Asset / SponsorPhaseRating
Topiramate
All India Institute of Medical Sciences, Bhubaneswar
Phase 4BBB
ATORVASTATIN
Seoul National University Hospital
Phase 4BBB
Pioglitazone
Philip Kern
Phase 4BBB
Rosuvastatin
Hamdard University
Phase 4BBB
OLMESARTAN MEDOXOMIL
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Phase 4BBB

View all 50 →

Same molecule, other indications

Itavastatin is also rated in:

coronary artery disorderDormant
BBB
Indicative · Phase 4
73 / 100
View asset →
inflammatory diseaseDormant
BB
Indicative · Phase 4
65 / 100
View asset →
inherited lipid metabolism disorderActive
BB
Indicative · Phase 3
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →